B+
Bull case
25%
Probability
Target price
$28.00
+260.4% vs current
LMRI
Lumexa ImagingN/ANasdaq / Health Care Equipment & Services
Last Price
At close
2026-06-03
AI scenario view
RankAlpha Sentiment AIMost likely
B
Base case
50%
Probability
Target price
$22.00
+183.1% vs current
B-
Bear case
25%
Probability
Target price
$12.00
+54.4% vs current
AI sentiment snapshot
Latest data as of 2026-03-27
Recent news sentiment (30D)
-26.5
Negative
Company
-
Unavailable
Macro
-26.5
Negative
Pulse
-
Unavailable
Sentiment proxy
+100.0
Score
AI commentary
Recent filings and IR material confirm company guidance and highlight expansion activity, which supports constructive analyst coverage and elevated targets [#8-K-2026-03-26] [#PR-2026-01-08]. Media/analyst coverage shows strong sell‑side price targets clustered near $22–$23, indicating bullish external expectations [#SERP-9]. Market tone is cautiously optimistic but sensitive to near‑term quarter results and execution updates [#IR-undated].
RankAlpha Sentiment AI - 2026-03-27
Open full AI memoEvidence flagged
No evidence quality warning is currently attached to this memo.
Impact
standard
Confidence
-
AI events
2026-06-25catalystNext quarterly earnings / call (near-term guidance reconciliation)High impact
Upcoming quarterly results and accompanying earnings call will provide near-term reconciliation to guidance and update on helium/operational dynamics referenced in recent coverage; monitor the next reported quarter following the 8‑K filing [#8-K-2026-03-26].
2026-12-31catalystExecution vs. 2026 guidance (volume & margin realization)High impact
Company provided full‑year 2026 financial guidance in its IR/press materials and 8‑K filing; market reaction will depend on procedure volumes and margin progress against that guidance [#IR-undated] [#8-K-2026-03-26].
2026-12-31catalystNetwork expansion drives outpatient volume growth (de‑novo openings)High impact
Company announced record de‑novo expansion (nine new outpatient centers in 2025); continued center openings and same‑store ramp could materially lift procedure volumes and revenue growth into 2026–2027 [#PR-2026-01-08].
Recommendation
N/A
No formal recommendation provided.
As of 2026-03-27 • Updated nightlySource: Internal modelMethodology